Container
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
- Antigen binding proteins to oncostatin M (OSM)
Description
The broken line portion of the figure drawings is included to show unclaimed subject matter only and forms no part of the claimed design.
Claims
The ornamental design for a container, as shown and described.
Referenced Cited
U.S. Patent Documents
D208828 | October 1967 | Braun |
3390809 | July 1968 | Becucci |
D245762 | September 13, 1977 | Takacs |
D292626 | November 3, 1987 | Chevassus |
D365206 | December 19, 1995 | Goodman |
D373952 | September 24, 1996 | Exarhos et al. |
D403176 | December 29, 1998 | Harper |
D406233 | March 2, 1999 | Kaplan |
D417077 | November 30, 1999 | Sheu |
D449165 | October 16, 2001 | van der Hulst |
D458127 | June 4, 2002 | de Groote |
D516801 | March 14, 2006 | Jones, III et al. |
D546173 | July 10, 2007 | Au |
D546671 | July 17, 2007 | Cronin et al. |
D549119 | August 21, 2007 | Becker |
D569103 | May 20, 2008 | Hoge et al. |
D623052 | September 7, 2010 | Giraud et al. |
D708940 | July 15, 2014 | Juna et al. |
D717161 | November 11, 2014 | Liu |
20090134209 | May 28, 2009 | Tonaltzin |
Patent History
Patent number: D728360
Type: Grant
Filed: Feb 5, 2014
Date of Patent: May 5, 2015
Assignee: Glaxo Group Limited (Brentford, Middlesex)
Inventor: Andrew Michael Kelly (Letchworth)
Primary Examiner: Robert M Spear
Assistant Examiner: Keith Frank
Application Number: 29/481,353
Type: Grant
Filed: Feb 5, 2014
Date of Patent: May 5, 2015
Assignee: Glaxo Group Limited (Brentford, Middlesex)
Inventor: Andrew Michael Kelly (Letchworth)
Primary Examiner: Robert M Spear
Assistant Examiner: Keith Frank
Application Number: 29/481,353
Classifications
Current U.S. Class:
D9/420